Article Text
Abstract
Rapidly progressive dementia mimicking Creutzfeldt–Jakob disease (CJD) is a relatively rare presentation but a rewarding one to become familiar with, as the potential diagnoses range from the universally fatal to the completely reversible. Patients require urgent decisions about assessment and investigation and have quickly evolving needs for treatments and support, through symptom management and end-of-life care in most cases. We have based this pragmatic review on the experiences of a specialist prion referral centre in the UK, which, unsurprisingly, is strongly biased towards seeing patients with CJD. Cases eventually proven not to have prion disease might be described as ‘CJD-mimics’; being referred from UK neurologists, these are the most challenging cases. CJD in its classical presentation is very rarely mimicked; however, it is highly heterogeneous, and atypical forms can mimic virtually all common neurodegenerative syndromes. Warning features of a mimic include generalised seizures, hyponatraemia, fever, a facial movement disorder, a normal neurological examination and a modestly rapid presentation. Contrast-enhancing lesions or MRI signal hyperintensity outside the striatum, thalamus or cortex and a cerebrospinal fluid pleocytosis are key investigation pointers to a CJD mimic.
- rapidly progressive dementia
Statistics from Altmetric.com
Linked Articles
- Editors' commentary
Read the full text or download the PDF:
Other content recommended for you
- Presence of voltage-gated potassium channel complex antibody in a case of genetic prion disease
- Diagnostic challenge of rapidly progressing sporadic Creutzfeldt-Jakob disease
- Neuroimaging findings in human prion disease
- Systematic approach to diagnosing suspected Creutzfeldt-Jakob disease
- Palliative care in Creutzfeldt-Jakob disease: looking back, thinking ahead
- Intensity of human prion disease surveillance predicts observed disease incidence
- An unusual case of sporadic Creutzfeldt-Jakob disease (CJD)
- MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type
- Molecular neurology of prion disease
- Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy